VECTIVBIO HLDG AG
ORD SHS · CUSIP H9060V101
29
institutional holders
+8 vs Q3 2022
42.7m
shares reported held*
$369.3mreported value*
7 new
8 added
5 reduced
0 sold out
net bought ≈ $127.6m (+14.7m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.65.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 21 |
| Q4 2022 | 29 |
Biggest buyers
| TCG Crossover Management, LLC | New | +2.3m |
| Vivo Capital, LLC | New | +2.3m |
| Venrock Adviser, LLC | New | +1.9m |
| CHI Advisors LLC | Added | +1.4m |
| Frazier Life Sciences Management, L.P. | New | +1.3m |
| Blackstone Inc. | New | +1.3m |
| EVENTIDE ASSET MANAGEMENT, LLC | Added | +1.1m |
| MARSHALL WACE, LLP | Added | +867.0k |
| Driehaus Capital Management LLC | Added | +861.9k |
| CITADEL ADVISORS LLC | Added | +822.6k |
Biggest sellers
| Balyasny Asset Management L.P. | Reduced | -19.3k |
| Tekla Capital Management LLC | Reduced | -18.8k |
| UBS Group AG | Reduced | -6.3k |
| JANE STREET GROUP, LLC | Reduced | -4.7k |
| CITIGROUP INC | Reduced | -300 |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLC 1.16% of their portfolio | 7.0m $60.7m | Added +533.3k |
| CHI Advisors LLC 12.68% of their portfolio | 5.5m $47.6m | Added +1.4m |
| CITADEL ADVISORS LLC 0.04% of their portfolio | 4.0m $34.2m | Added +822.6k |
| EVENTIDE ASSET MANAGEMENT, LLC 0.58% of their portfolio | 3.4m $29.3m | Added +1.1m |
| NOVO HOLDINGS A/S 1.81% of their portfolio | 3.3m $28.9m | Unchanged |
| Bpifrance SA 0.80% of their portfolio | 2.8m $24.3m | Unchanged |
| Cormorant Asset Management, LP 1.48% of their portfolio | 2.5m $22.0m | Unchanged |
| Vivo Capital, LLC 2.33% of their portfolio | 2.3m $20.2m | New |
| TCG Crossover Management, LLC 3.57% of their portfolio | 2.3m $20.2m | New |
| Venrock Adviser, LLC 2.72% of their portfolio | 1.9m $16.2m | New |
| Driehaus Capital Management LLC 0.22% of their portfolio | 1.7m $14.8m | Added +861.9k |
| MARSHALL WACE, LLP 0.03% of their portfolio | 1.4m $11.8m | Added +867.0k |
| Frazier Life Sciences Management, L.P. 0.71% of their portfolio | 1.3m $11.5m | New |
| Blackstone Inc. 0.04% of their portfolio | 1.3m $11.6m | New |
| Tekla Capital Management LLC 0.24% of their portfolio | 737.7k $6.4m | Reduced -18.8k |
| Balyasny Asset Management L.P. 0.01% of their portfolio | 343.3k $3.0m | Reduced -19.3k |
| UBS Group AG 0.00% of their portfolio | 253.9k $2.2m | Reduced -6.3k |
| NATIONAL BANK OF CANADA /FI/ 0.00% of their portfolio | 165.3k $1.4m | Unchanged |
| CAXTON CORP 3.44% of their portfolio | 156.2k $1.3m | Added +15.4k |
| CITIGROUP INC 0.00% of their portfolio | 81.3k $699.8k | Reduced -300 |
| Canaan Partners XI LLC 0.25% of their portfolio | 37.1k $320.9k | Unchanged |
| PFM Health Sciences, LP 0.01% of their portfolio | 25.5k $221.3k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 23.1k $198.0k | Unchanged |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 19.2k $166.7k | Reduced -4.7k |
| BARCLAYS PLC 0.00% of their portfolio | 9.4k $81.5k | First filing |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 4.4k $38.0k | Added +2.2k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 4.2k $36.3k | New |
| MORGAN STANLEY 0.00% of their portfolio | 2.3k $19.6k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |